|
Sri Sriadibhatla, PhD
Investment Director, Healthcare Investment Group (HIG)
Ben Franklin Technology Partners of Southeastern PA
|
Sri Sriadibhatla is Investment Director, Healthcare Investment Group (HIG) at Ben Franklin Technology Partners of SEP. Sri works closely with the Managing Director, and is responsible for sourcing, diligence, negotiating, and managing investments in early-stage companies in the healthcare sector. He has extensive experience in the drug discovery & development, formulations, regulatory, and commercialization process.
Prior to joining Ben Franklin, Sri worked as Technology Scout at FMC Corporation and led initiatives in developing, adapting, streamlining, and executing an Open Innovation model. He has over 14 years of experience in technology evaluation, licensing, investment and commercialization. Sri is a registered pharmacist and holds a PhD in Pharmaceutical Sciences (Center for Drug Delivery and Nanomedicine) from the University of Nebraska Medical Center.
Prior to joining Ben Franklin, Sri worked as Technology Scout at FMC Corporation and led initiatives in developing, adapting, streamlining, and executing an Open Innovation model. He has over 14 years of experience in technology evaluation, licensing, investment and commercialization. Sri is a registered pharmacist and holds a PhD in Pharmaceutical Sciences (Center for Drug Delivery and Nanomedicine) from the University of Nebraska Medical Center.